Jiménez-Rojas Verónica, Villanueva-García Dina, Miranda-Vega Ana Luisa, Aldana-Vergara Rubén, Aguilar-Rodea Pamela, López-Marceliano Beatriz, Reyes-López Alfonso, Alcántar-Curiel María Dolores
Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico.
Departamento de Neonatología, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico.
Front Cell Infect Microbiol. 2024 Jan 19;13:1322874. doi: 10.3389/fcimb.2023.1322874. eCollection 2023.
The gut microbiota harbors diverse bacteria considered reservoirs for antimicrobial resistance genes. The global emergence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales (ESBL-PE) significantly contributes to healthcare-associated infections (HAIs). We investigated the presence of ESBL-producing (ESBL-PEco) and ESBL-producing (ESBL-PKpn) in neonatal patients' guts. Furthermore, we identified the factors contributing to the transition towards ESBL-PEco and ESBL-PKpn-associated healthcare-associated infections (HAIs). The study was conducted from August 2019 to February 2020, in a Neonatal Intensive Care Unit of the Hospital Infantil de México Federico Gómez. Rectal samples were obtained upon admission, on a weekly basis for a month, and then biweekly until discharge from the neonatology ward. Clinical data, culture results, and infection information were gathered. We conducted antimicrobial tests, multiplex PCR assay, and pulsed-field gel electrophoresis (PFGE) to determine the antimicrobial resistance profile and genetic relationships. A comparison between the group's controls and cases was performed using the Wilcoxon and Student t-tests. Of the 61 patients enrolled, 47 were included, and 203 rectal samples were collected, identifying 242 isolates. In 41/47 (87%) patients, colonization was due to ESBL-PEco or ESBL-PKpn. And nine of them developed HAIs (22%, 9/41). ESBL-PEco resistance to cephalosporins ranged from 25.4% to 100%, while ESBL-PKpn resistance varied from 3% to 99%, and both bacteria were susceptible to carbapenems, tigecillin, and colistin. The prevalent gene accounted for 77.2% in ESBL-PEco and 82.2% in ESBL-PKpn, followed by 50% and 43.8% in ESBL-PEco and 80.2% and 76.2% in ESBL-PKpn. Analysis of clonality revealed identical colonizing and infection isolates in only seven patients. Significant risk factors included hospital stay duration, duration of antibiotic treatment, and invasive device usage. Our findings suggest high ESBL-PEco and ESBL-PKpn rates of colonization often lead to infection in neonates. Attention should be paid to patients with ESBL-PE.
肠道微生物群中含有多种细菌,这些细菌被认为是抗菌药物耐药基因的储存库。产超广谱β-内酰胺酶(ESBL)的肠杆菌科细菌(ESBL-PE)在全球范围内的出现,显著促成了医疗保健相关感染(HAIs)。我们调查了新生儿患者肠道中产ESBL的大肠杆菌(ESBL-PEco)和产ESBL的肺炎克雷伯菌(ESBL-PKpn)的存在情况。此外,我们还确定了促成向与ESBL-PEco和ESBL-PKpn相关的医疗保健相关感染(HAIs)转变的因素。该研究于2019年8月至2020年2月在墨西哥费德里科·戈麦斯儿童医院的新生儿重症监护病房进行。入院时采集直肠样本,在一个月内每周采集一次,然后每两周采集一次,直至从新生儿病房出院。收集临床数据、培养结果和感染信息。我们进行了抗菌测试、多重PCR检测和脉冲场凝胶电泳(PFGE),以确定抗菌药物耐药谱和遗传关系。使用Wilcoxon检验和Student t检验对该组的对照组和病例组进行比较。在纳入的61名患者中,47名被纳入研究,共采集了203份直肠样本,鉴定出242株分离株。在41/47(87%)的患者中,定植是由ESBL-PEco或ESBL-PKpn引起的。其中9人发生了医疗保健相关感染(22%,9/41)。ESBL-PEco对头孢菌素的耐药率在25.4%至100%之间,而ESBL-PKpn的耐药率在3%至99%之间,两种细菌对碳青霉烯类、替加环素和黏菌素均敏感。流行的blaCTX-M基因在ESBL-PEco中占77.2%,在ESBL-PKpn中占82.2%,其次是blaSHV在ESBL-PEco中占50%和blaTEM占43.8%,在ESBL-PKpn中blaSHV占80.2%和blaTEM占76.2%。克隆性分析显示,只有7名患者的定植和感染分离株相同。显著的危险因素包括住院时间、抗生素治疗时间和侵入性器械的使用。我们的研究结果表明,ESBL-PEco和ESBL-PKpn的高定植率常常导致新生儿感染。应关注携带ESBL-PE的患者。